Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS 2 score

European Journal of Echocardiography

Volumn 10, Issue 3, 2009, Pages 383-388

  Kleemann, Thomas ^a   Becker, Torsten ^a   Strauss, Margit ^a   Schneider, Steffen ^b   Seidl, Karlheinz ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Atrial fibrillation; CHADS 2; Spontaneous echo contrast; Thrombus; Transoesophageal echocardiography

Indexed keywords

HEPARIN; PHENPROCOUMON;

ADULT; AGED; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; STROKE; THROMBOSIS;

EID: 64749106389     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jen256     Document Type: Article

References (29)

1. Pearce LA, Hart RG, Halperin JL. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Am J Med 2000; 109:45-51.
2. Gage BF, Watermann AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. J Am Med Assoc 2001; 285:2864-70.
3. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 154: 1449-57.
4. Inoue H, Nozawa T, Hirai T, Iwasa A, Okumura K, Lee JD et al. Accumulation of risk factors increases risk of thromboembolic events in patients with nonvalvular atrial fibrillation. Circ J 2006; 70:651-6.
5. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BSP et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004; 110:2287-92.
6. Atrial Fibrillation Investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998; 158:1316-20.
7. Stroke Prevention in Atrial Fibrillation Investigators. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation study. J Stroke Cerebro-vasc Dis 1995; 5:147-57.
8. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echocardiographic features of patients at risk. Ann Intern Med 1992; 116:6-12.
9. Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk: a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 2005; 45:1807-12.
10. Illien S, Maroto-Järvinen S, von der Recke G, Hammerstingl C, Schmidt H, Kuntz-Hehner S et al. Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism. Heart 2003; 89:165-8.
11. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol 1998; 31: 1622-6.
12. Kleemann T, Becker T, Doenges K, Vater M, Gut B, Schneider S et al. The prognostic impact of successful cardioversion of atrial fibrillation in patients with organic heart disease. Clin Res Cardio l 2007; 96: 103-8.
13. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL et al. ACC/ AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) Developed in Collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104:2118-50.
14. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8:651-745.
15. Vincelj J, Sokol I, Jaksic O. Prevalence and clinical significance of left atrial spontaneous echo contrast detected by transesophageal echocardiography. Echocardiography 2002; 19:319-24.
16. The Atrial Fibrillation Investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998; 158:1316-20.
17. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 1992; 116:6-12.
18. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE et al. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 2005; 96:935-41.
19. Stöllberger C, Chnupa P, Kronik G, Brainin M, Finsterer J, Schneider B et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in left atrial thrombi. Ann Intern Med 1998; 128:630-8.
20. Abe Y, Asakura T, Gotou J, Iwai M, Watanabe Y, Sando M et al. Prediction of embolism in atrial fibrillation: classification of left atrial thrombi by transesophageal echocardiography. Jpn Circ J 2000; 64:411-5.
21. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation 1995; 92:2178-82.
22. Corrado G, Tadeo G, Beretta S, Tagliagambe LM, Manzillo GF, Spata M et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest 1999; 115:140-3.
23. Collins LJ, Silverman DI, Douglas PS, Manning WJ. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation 1995; 92:160-3.
24. The AFFIRM Investigators. Survival of patients presenting with atrial fibrillation in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. N Engl J Med 2002; 347:1825-33.
25. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma Tet al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347:1834-40.
26. Bernhardt P, Schmidt H, Sommer T, Luderitz B, Omran H. Atrial fibrillation - patients at high risk for cerebral embolism. Clin Res Cardiol 2006; 95:148-53.
27. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23:961-9.
28. MiyazakiS, ItoT, Suwa M, NakamuraT, Kobashi A, Kitaura Y. Role of transesophageal echocardiography in the prediction of thromboembolism in patients with chronic nonvalvular atrial fibrillation. Jpn Circ J 2001; 65:874-8.
29. Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Atrial thrombi - a prospective follow-up study over 3 years with transesophageal echocardiography and cranial magnetic resonance imaging. Echocardiography 2006; 23:388-94.